Question 1

Who are the latest insiders trading Seres Therapeutics, Inc. (MCRB) stock?

Accepted Answer

The most recent insider trade for Seres Therapeutics, Inc. (MCRB) was by Rosiello Robert L. on August 5, 2025, who executed a purchase of 10,000 shares at $14.28 per share.

Question 2

How much MCRB stock was sold by insiders this month?

Accepted Answer

There have been no insider sales recorded for Seres Therapeutics, Inc. (MCRB) in the past 30 days. This could suggest insiders are holding their positions.

Question 3

Does Seres Therapeutics, Inc. show consistent insider selling or buying?

Accepted Answer

Over the last 12 months, insider activity at Seres Therapeutics, Inc. (MCRB) shows a general trend of buying, with 0 sale transactions and 7 purchase transactions recorded.

Question 4

Are executives at Seres Therapeutics, Inc. actively trading their shares?

Accepted Answer

Yes, recent executive trades have been recorded. For example, Rosiello Robert L. reported a purchase of 10,000 shares on 8/5/2025.

Seres Therapeutics, Inc.